213 related articles for article (PubMed ID: 31326251)
1. Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya.
Wambura G; Mwatondo A; Muturi M; Nasimiyu C; Wentworth D; Hampson K; Bichanga P; Tabu C; Juma S; Ngere I; Thumbi SM
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A28-A34. PubMed ID: 31326251
[TBL] [Abstract][Full Text] [Related]
2. Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017-2018.
Sreenivasan N; Li A; Shiferaw M; Tran CH; Wallace R; Blanton J; Knopf L; Abela-Ridder B; Hyde T;
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A6-A13. PubMed ID: 31471150
[TBL] [Abstract][Full Text] [Related]
3. The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania.
Changalucha J; Steenson R; Grieve E; Cleaveland S; Lembo T; Lushasi K; Mchau G; Mtema Z; Sambo M; Nanai A; Govella NJ; Dilip A; Sikana L; Ventura F; Hampson K
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A45-A53. PubMed ID: 30309746
[TBL] [Abstract][Full Text] [Related]
4. Rabies Elimination in Rural Kenya: Need for Improved Availability of Human Vaccines, Awareness and Knowledge on Rabies and Its Management Among Healthcare Workers.
Chuchu VM; Kitala PM; Bichanga P; Ksee D; Muturi M; Mwatondo A; Nasimiyu C; Maritim M; Mutono N; Beyene TJ; Druelles S; Hampson K; Thumbi SM
Front Public Health; 2022; 10():769898. PubMed ID: 35356016
[TBL] [Abstract][Full Text] [Related]
5. Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017-2018.
Li AJ; Sreenivasan N; Siddiqi UR; Tahmina S; Penjor K; Sovann L; Gunesekera A; Blanton JD; Knopf L; Hyde TB
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A14-A19. PubMed ID: 30314908
[TBL] [Abstract][Full Text] [Related]
6. Assessment of procurement, distribution, availability, and utilization of rabies biologicals for postexposure prophylaxis in seven states of India.
D Hanumanthaiah AN; Haradanhalli RS
Indian J Public Health; 2019 Sep; 63(Supplement):S31-S36. PubMed ID: 31603089
[TBL] [Abstract][Full Text] [Related]
7. Modelling to inform prophylaxis regimens to prevent human rabies.
Hampson K; Abela-Ridder B; Bharti O; Knopf L; Léchenne M; Mindekem R; Tarantola A; Zinsstag J; Trotter C
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A166-A173. PubMed ID: 30528846
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and surveillance of human animal-bite injuries and rabies post-exposure prophylaxis, in selected counties in Kenya, 2011-2016.
Ngugi JN; Maza AK; Omolo OJ; Obonyo M
BMC Public Health; 2018 Aug; 18(1):996. PubMed ID: 30092769
[TBL] [Abstract][Full Text] [Related]
9. Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by "pooling strategy".
Bharti OK; Thakur B; Rao R
Vaccine; 2019 Oct; 37 Suppl 1():A128-A131. PubMed ID: 31395454
[TBL] [Abstract][Full Text] [Related]
10. Rabies post-exposure prophylaxis initiation and adherence among patients in Vietnam, 2014-2016.
Tran CH; Afriyie DO; Pham TN; Otsu S; Urabe M; Dang AD; Tran HGT; Nguyen HV; Le HT; Nguyen HTT
Vaccine; 2019 Oct; 37 Suppl 1():A54-A63. PubMed ID: 30723063
[TBL] [Abstract][Full Text] [Related]
11. An epidemiological study of suspected rabies exposures and adherence to rabies post-exposure prophylaxis in Eastern Thailand, 2015.
Yurachai O; Hinjoy S; Wallace RM
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007248. PubMed ID: 32106251
[TBL] [Abstract][Full Text] [Related]
12. On the path to rabies elimination: The need for risk assessments to improve administration of post-exposure prophylaxis.
Rysava K; Miranda ME; Zapatos R; Lapiz S; Rances P; Miranda LM; Roces MC; Friar J; Townsend SE; Hampson K
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A64-A72. PubMed ID: 30573356
[TBL] [Abstract][Full Text] [Related]
13. Facilities and services of postexposure prophylaxis in anti-rabies clinics: A national assessment in India.
Sudarshan MK; Haradanhalli RS
Indian J Public Health; 2019 Sep; 63(Supplement):S26-S30. PubMed ID: 31603088
[TBL] [Abstract][Full Text] [Related]
14. Background paper for developing a policy for the use of rabies biologicals and vaccination of humans in India.
Sudarshan MK; Ashwath Narayana DH
Indian J Public Health; 2019 Sep; 63(Supplement):S51-S53. PubMed ID: 31603093
[TBL] [Abstract][Full Text] [Related]
15. Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course.
Kessels J; Tarantola A; Salahuddin N; Blumberg L; Knopf L
Vaccine; 2019 Oct; 37 Suppl 1():A107-A117. PubMed ID: 30737043
[TBL] [Abstract][Full Text] [Related]
16. Rabies Vaccine and Rabies Immunoglobulin in Cambodia: Use and Obstacles to Use.
Tarantola A; Ly S; In S; Ong S; Peng Y; Heng N; Buchy P
J Travel Med; 2015; 22(5):348-52. PubMed ID: 26173470
[TBL] [Abstract][Full Text] [Related]
17. Global characteristics of the rabies biologics market in 2017.
Ives A; Dieuzy-Labaye I; Abela-Ridder B
Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A73-A76. PubMed ID: 30420115
[TBL] [Abstract][Full Text] [Related]
18. Postexposure prophylaxis for rabies in resource-limited/poor countries.
Shantavasinkul P; Wilde H
Adv Virus Res; 2011; 79():291-307. PubMed ID: 21601051
[TBL] [Abstract][Full Text] [Related]
19. RABIES IMMUNOGLOBULIN: Brief history and recent experiences in Côte d'Ivoire.
Gerber F; Tetchi M; Kallo V; Léchenne M; Hattendorf J; Bonfoh B; Zinsstag J
Acta Trop; 2020 Nov; 211():105629. PubMed ID: 32659281
[TBL] [Abstract][Full Text] [Related]
20. Rabies vaccination at a virus-inoculated site as an alternative option to rabies immunoglobulin.
Morimoto K; Khawplod P; Sato Y; Virojanapirom P; Hemachudha T
Arch Virol; 2016 Sep; 161(9):2537-41. PubMed ID: 27270361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
